University research records
Université de Nantes
6 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →6 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Université de Nantes are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–6 of 6 matching records. Counts update as records arrive.
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial
March 4, 2021 · 170 citations · Open access
Open original record →Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
October 7, 2020 · 1,228 citations · Open access
Open original record →Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)
September 5, 2018 · 204 citations · Open access
Open original record →Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathways
July 23, 2018 · 83 citations · Open access
Open original record →Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy ( VERTIS MET )
August 31, 2017 · 184 citations · Open access
Open original record →The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
January 4, 2017 · 151 citations · Open access
Open original record →